Creative Ways to Market Your Technology While Navigating the Regulatory Landscape

12 years ago, when Ziv Peremen transitioned from a PhD in neurocognitive science to a self-described applicative side of the field, he didn’t think he was going to become a co-founder of a medtech startup that would eventually raise $4.5 million in seed funding. 

That company, X-trodes, was started by Ziv and Yael Hanin, a professor at Tel Aviv University with an impressive background as a human-machine interface expert, and inventor of the innovative sensor technology that X-trodes is built on.

X-trodes manufactures Smart Skin, unique medical-grade wearable sensors that monitor sleep. X-trodes also manufactures multi-electrode patches that measure real-time muscle patterns and fatigue.

In this Medsider conversation, learn how X-trodes discovered a creative way to introduce their technology to the market before regulatory approval and how this strategy has opened numerous doors for the company, including partnerships with well-known players.

Key Learnings from Ziv’s Experience

• When developing your technology, think about creative ways to potentially commercialize in advance of regulatory approval. For X-trodes, that meant selling their product as part of a research kit, which has led to critical learnings for the company.

• Focus on building a solid company infrastructure from the start. Don’t skimp during this period as it’s critical for discovering the kinks in your technology, receiving key feedback from end users, and partnering with impactful players.  

• Avoid manufacturing custom products that are not critical to your core technology stack. Invest more resources in finding off-the-shelf solutions rather than depleting your budget trying to recreate the wheel. 

‍